1. Home
  2. TWI vs LRMR Comparison

TWI vs LRMR Comparison

Compare TWI & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan International Inc. (DE)

TWI

Titan International Inc. (DE)

HOLD

Current Price

$7.17

Market Cap

494.4M

Sector

Industrials

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.19

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWI
LRMR
Founded
1890
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
494.4M
455.8M
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
TWI
LRMR
Price
$7.17
$3.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$12.00
$16.50
AVG Volume (30 Days)
411.8K
1.7M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.69
N/A
Revenue Next Year
$4.85
$1,816.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.43
$2.26
52 Week High
$11.70
$6.42

Technical Indicators

Market Signals
Indicator
TWI
LRMR
Relative Strength Index (RSI) 42.65 31.98
Support Level $7.20 $3.10
Resistance Level $8.38 $3.74
Average True Range (ATR) 0.30 0.19
MACD 0.03 -0.01
Stochastic Oscillator 24.86 3.64

Price Performance

Historical Comparison
TWI
LRMR

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. It designs and manufactures products for OEMs and aftermarket customers in the agricultural, earthmoving/construction, and consumer markets. The company operates through three segments, namely Agricultural, Earthmoving/Construction, and Consumer. It derives the majority of revenue from the Agricultural segment which manufactures various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment. Geographically, the company generates the maximum revenue from North America, followed by Europe / CIS, Latin America, and Asia and other regions.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: